Value Bridge — ST MARYS MEDICAL CENTER
Current $36M → Target $46M (+$9.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$35.7M
Current EBITDA
$45.6M
Target EBITDA
+$9.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.2M
Payer Mix Optimization
$5.4M
Cost to Collect Reduction
$1.8M
Clean Claim Improvement
$1.3M
Volume & Rate Growth
$8.9M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $36M to $46M. The highest-impact lever is Volume & Rate Growth at $3.6M probability-weighted.
IC talking point: "We see $10M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $109M in equity value creation."